|
|
|
|
|
|
|
|
|
|
open access
REFERENCES
1. Friedlander ML, Stockler MR, Butow P, et al: Clinical trials of palliative chemotherapy in platinum-resistant or -refractory ovarian cancer: Time to think differently? J Clin Oncol doi: 10.1200/JCO.2012.47.7927
2. Colombo N, Kutarska E, Dimopoulos M, et al: Randomized, open-label, phase III study comparing patupilone (EPO906) with pegylated liposomal doxorubicin in platinum-refractory or -resistant patients with recurrent epithelial ovarian, primary fallopian tube, or primary peritoneal cancer. J Clin Oncol 30:3841-3847, 2012
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.